GB201409877D0 - Composition pharmaceutical composition of protease inhibitors and production thereof - Google Patents

Composition pharmaceutical composition of protease inhibitors and production thereof

Info

Publication number: GB201409877D0
Authority: GB; United Kingdom
Prior art keywords: composition; production; protease inhibitors; pharmaceutical composition; composition pharmaceutical
Prior art date: 2011-11-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

GBGB1409877.6A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ZHIRNOV OLEG P

Original Assignee

ZHIRNOV OLEG P

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-11-03

Filing date

2012-11-01

Publication date

2014-07-16

2012-11-01 Application filed by ZHIRNOV OLEG P filed Critical ZHIRNOV OLEG P

2014-07-16 Publication of GB201409877D0 publication Critical patent/GB201409877D0/en

2014-08-20 Publication of GB2511011A publication Critical patent/GB2511011A/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Zoology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

GB1409877.6A 2011-11-03 2012-11-01 Aerosol pharmaceutical composition of protease inhibitors and production thereof Withdrawn GB2511011A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
RU2011144624A RU2657523C2 (en)	2011-11-03	2011-11-03	Pharmaceutical aerosol composition of protease inhibitors with ozone-preserving propellant and its preparation
PCT/RU2012/000896 WO2013066214A2 (en)	2011-11-03	2012-11-01	Aerosol pharmaceutical composition of protease inhibitors and production thereof

Publications (2)

Publication Number	Publication Date
GB201409877D0 true GB201409877D0 (en)	2014-07-16
GB2511011A GB2511011A (en)	2014-08-20

Family

ID=48192963

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB1409877.6A Withdrawn GB2511011A (en)	2011-11-03	2012-11-01	Aerosol pharmaceutical composition of protease inhibitors and production thereof

Country Status (4)

Country	Link
EA (1)	EA034991B1 (en)
GB (1)	GB2511011A (en)
RU (1)	RU2657523C2 (en)
WO (1)	WO2013066214A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2711080C2 (en) *	2015-06-15	2020-01-15	Олег Петрович Жирнов	Combined aerosol composition based on protease inhibitors and preparation thereof
WO2022216172A1 (en) *	2021-04-06	2022-10-13	Андрей Александрович ИВАЩЕНКО	Aqueous aprotinin-containing antiviral pharmaceutical composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2656944B2 (en) *	1987-04-30	1997-09-24	クーパーラボラトリーズ	Aerosolization of protein therapeutics
RU2054180C1 (en) *	1991-08-21	1996-02-10	Жирнов Олег Петрович (н/п)	Method and aerosol for treating respiratory virus infections
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US20010006939A1 (en) *	1997-10-03	2001-07-05	Ralph W. Niven	Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US6849263B2 (en) *	1998-12-21	2005-02-01	Generex Pharmaceutical Incorporated	Pharmaceutical compositions for buccal delivery of pain relief medications
US6294153B1 (en) *	1998-12-21	2001-09-25	Generex Pharmaceuticals, Inc.	Aerosol pharmaceutical formulation for pulmonary and nasal delivery
WO2000074736A1 (en) *	1999-06-04	2000-12-14	Delrx Pharmaceutical Corporation	Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
AU3664102A (en) *	2000-12-01	2002-06-11	Battelle Memorial Institute	Method for stabilizing biomolecules in liquid formulations
GB0507577D0 (en) *	2005-04-14	2005-05-18	Novartis Ag	Organic compounds
RU2356537C2 (en) *	2007-07-25	2009-05-27	Закрытое Акционерное Общество (ЗАО) "Пульмомед"	Pharmaceutical composition of metered aerosols containing antiasthmatic agents in form of suspensions, solutions, emulsions, solutions and emulsions
RU2425691C1 (en) *	2010-07-15	2011-08-10	ВАКЕ спол с.р.о.	Aprotinin aerosol for treating viral respiratory infections

2011
- 2011-11-03 RU RU2011144624A patent/RU2657523C2/en not_active Application Discontinuation
2012
- 2012-10-27 EA EA201201362A patent/EA034991B1/en not_active IP Right Cessation
- 2012-11-01 GB GB1409877.6A patent/GB2511011A/en not_active Withdrawn
- 2012-11-01 WO PCT/RU2012/000896 patent/WO2013066214A2/en not_active Ceased

Also Published As

Publication number	Publication date
GB2511011A (en)	2014-08-20
RU2657523C2 (en)	2018-06-14
EA034991B1 (en)	2020-04-15
EA201201362A1 (en)	2013-05-30
WO2013066214A2 (en)	2013-05-10
RU2011144624A (en)	2013-05-10
WO2013066214A3 (en)	2013-08-22

Publication	Publication Date	Title
ZA201401117B (en)	2017-09-27	Kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof
IL253911A0 (en)	2017-10-31	Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
EP2678018A4 (en)	2015-09-30	Combination of kanase inhibitors and uses thereof
IL230705A0 (en)	2014-03-31	Certain kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof
IL231203A (en)	2017-04-30	Selective and reversible inhibitors of ubiquitin specific protease 7, pharmaceutical compositions thereof and their therapeutic applications
EP2566331A4 (en)	2013-09-18	Pharmaceutical compositions and methods of making same
ZA201307956B (en)	2015-01-28	Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
IL234884A0 (en)	2014-12-31	Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
GB2503842B (en)	2014-10-08	Composition and method of manufacture
ZA201402167B (en)	2014-11-26	Compositions of lopinavir and ritonavir
SI2706062T1 (en)	2018-11-30	Novel cephalosporin derivative and pharmaceutical composition thereof
IL231069B (en)	2018-02-28	Inhibitors of nedd 8- activating enzyme
PT3071218T (en)	2019-01-30	Pharmaceutical composition containing a mixture of proenzymes and enzymes
HUE036400T2 (en)	2018-07-30	Pharmaceutical composition of omeprazole
IL231505A0 (en)	2014-04-30	Pharmaceutical composition and method of preparing same
SG10201604468QA (en)	2016-07-28	Shk-based pharmaceutical compositions and methods of manufacturing and using the same
GB201409877D0 (en)	2014-07-16	Composition pharmaceutical composition of protease inhibitors and production thereof
IL231490A0 (en)	2014-04-30	Compositions and methods for the production and use of human cholinesterases
IL229427A0 (en)	2014-01-30	Process for the preparation of protease inhibitors
HK1192727A (en)	2014-08-29	Combination of kanase inhibitors and uses thereof

Legal Events

Date	Code	Title	Description
2019-10-30	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)